Publications

5674 Results

The relationship between a priori defined prognostic risk groups and overall survival (OS) in men with metastatic hormone sensitive prostate cancer (mHSPC)

Authors
H Halabi;A Roy;S Guo;L Rydzewska;P Godolphin;M Hussain;C Tangen;IM Thompson;M Carducci;M Smith;M Morris;G Gravis;D Dearnlavey;P Verhagen;T Goto;J Tierney;N James;N James;M Buyse;C Sweeney
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 5073); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

Relationship between ABO blood group alleles and pancreatic cancer is modulated by secretor (FUT2) genotype, but not Lewis antigen (FUT3) genotype

Authors
J Kim;C Yuan;L Amundadottir;B Wolpin;A Klein;H Risch;P Kraft;Panc Ca Consort (P Goodman)
Journal / Conference
Cancer Epidemiology, Biomarkers, and Prevention Sep 1;32(9):1242-1248
Year
2023
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID37342060
PMC
PMC10527950
Study Number(s)
S0000

A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk

Authors
E Aglago;A Kim;Y Lin;C Qu;M Evangelou;Y Ren;J Morrison;D Albanes;V Arndt;E Barry;J Baurley;S Berndt;S Bien;D Bishop;E Bouras;H Brenner;D Buchanan;A Budiarto;R Carreras-Torres;G Casey;T Cenggoro;A Chan;J Chang-Claude;X Chen;D Conti;M Devall;N Dimou;D Drew;J Figueiredo;S Gallinger;G Giles;S Gruber;A Gsur;M Gunter;H Hampel;S Harlid;A Hidaka;T Harrison;M Hoffmeister;J Huyghe;M Jenkins;K Jordahl;A Joshi;E Kawaguchi;T Keku;A Kundaje;S Larrson;L LeMarchand;J Lewinger;B Lynch;B Mahesworo;M Mandic;M Obon-Santacana;M Moreno;N Murphy;H Nan;R Nassir;P Newcomb;S Ogino;J Ose;R Pai;J Palmer;N Papadimitriou;B Pardamean;A Peoples;E Platz;J Potter;R Prentice;G Rennert;E Ruiz-Narvaez;L Sakoda;P Scacheri;S Schmidt;R Schoen;A Shcherbina;M Slattery;M Stern;Y Su;C Tangen;S Thibodeau;D Thomas;Y Tian;C Ulrich;F van Duijnhoven;B Van Guelpen;K Visvanathan;P Vodicka;J Wang;E White;A Wolk;M Woods;H Wu;N Zemlianskaia;L Hsu;W Gauderman;U Peters;K Tsilidis;P Campbell
Journal / Conference
Cancer Research Aug 1;83(15):2572-2583
Year
2023
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID37249599
PMC
PMC10391330
Study Number(s)
S0000

Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

Authors
C Fernandez-Rozadilla;M Timofeeva;Z Chen;P Law;M Thomas;S Schmidt;D Albanes;E Platz;H-J Lenz;C Tangen;S Gruber;I Tomlinson;W Zheng;M Dunlop;R Houlston;U Peters
Journal / Conference
NATURE GENETICS
Year
2023
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance)

Authors
S Lee;C Ma;Q Shi;J Meyer;P Kumar;F Coutoure;P Kuebler;D Lewis;B Tan;E O'Reilly;A Shields;J Meyerhardt
Journal / Conference
Br J Cancer, Aug;129(2):283-290
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID37179438
PMC
PMC10338523
Study Number(s)
CTSU/C80702

Baseline quality of life is a strong and independent prognostic factor for overall survival in metastatic colorectal cancer

Authors
P McGarrah;J Hubbard;P Novatny;M Branda;D Sargent;R Morton;C Fuchs;R Ramanathan;S Williamson;B Findlay;S Alberts;R Goldberg;J Sloan
Journal / Conference
Cancer Control Jan-Dec;30:10732748231185047
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID37339926
PMC
PMC10286175
Study Number(s)
N9741

Long term outcomes from a phase II study of neoadjuvant chemotherapy for muscle invasive bladder cancer (SWOG S1314; NCT02177695)

Authors
T Flaig;C Tangen;S Daneshmand;A Alva;MS Lucia;D McConkey;D Theodorescu;A Goldkorn;M Milowsky;R Bangs;G MacVicar;B Bastos;J Fowles;D Gustafson;M Plets;I Thompson;S Lerner
Journal / Conference
European Urology Sep;84(3):341-347
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID37414705
PMC
PMC10659139
Study Number(s)
S1314

Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)

Authors
M Morris;G Heller;D Hillman;O Conway;C Ryan;E Antonarakis;A Bryce;O Hahn;H Beltran;A Armstrong;L Schwartz;L Lewis;J Beumer;B Langevin;E McGary;P Mehan;A Goldkorn;B Roth;H Xiao;C Watt;M Taplin;S Halabi;E Small
Journal / Conference
Journal of Clinical Oncology Jun 20;41(18):3352-3362
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID36996380
Study Number(s)
CTSU/A031201

Preoperative Treatment of Locally Advanced Rectal Cancer

Authors
D Schrag;Q Shi;M Weiser;M Gollub;L Saltz;B Musher;J Goldberg;T Al Baghdadi;K Goodman;R McWilliams;J Farma;T George;H Kennecke;M Montemurro;G Nelson;B Colgrove;V Gordon;A Venook;E O'Reilly;J Meyerhardt;A Dueck;E Basch;G Chang;H Mamon
Journal / Conference
New England Journal of Medicine
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID37272534
PMC
PMC10775881
Study Number(s)
CTSU/N1048

Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the N1048 PROSPECT trial

Authors
E Basch;A Dueck;S Mitchell;H Mamon;M Weiser;L Saltz;M Gollub;L Rogak;B Ginos;G Mazza;B Colgrove;G Chang;L Minasian;A Denicoff;G Thanarajasingam;B Musher;T George;A Venook;J Farma;E O'Reilly;J Meyerhardt;Q Shi;D Schrag
Journal / Conference
Journal of Clinical Oncology
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID37270691
PMC
PMC10351948
Study Number(s)
CTSU/N1048